D. E. Shaw & Co., Inc. Stevanato Group S.P.A. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$16.93 - $31.33 $783,672 - $1.45 Million	-46,289 Reduced 69.36%	20,446 $374,000
Q1 2024 May 15, 2024	SELL	$25.34 - $34.28 $1.16 Million - $1.57 Million	-45,717 Reduced 40.65%	66,735 $2.14 Million
Q4 2023 Feb 14, 2024	SELL	$25.21 - $34.66 $176,016 - $241,996	-6,982 Reduced 5.85%	112,452 $3.07 Million
Q3 2023 Nov 14, 2023	BUY	$26.91 - $35.49 $1.02 Million - $1.35 Million	37,979 Added 46.63%	119,434 $3.55 Million
Q2 2023 Aug 14, 2023	BUY	$25.15 - $32.86 $1.64 Million - $2.14 Million	65,041 Added 396.25%	81,455 $2.64 Million
Q1 2023 May 15, 2023	BUY	$17.5 - $25.9 $287,245 - $425,122	16,414 New	16,414 $425,000

133

54.8M

2.7K

Ticker STVN
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 264,700,000
Market Cap $5.44B
Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.